CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash Flows From Operating Activities:
Net Loss	$ (26,825,602)	$ (22,749,945)
Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities:
Depreciation and Amortization	581,982	466,994
Stock-based Compensation	3,895,041	2,425,919
Increase in Inventory Reserves	1,271,000	3,442,547
Amortization of Right of Use Asset	1,429,727
(Gain) Loss on Disposal of Assets	(620)	4,030
Realized (Gain) Loss on Sale of Investments Available-for-Sale	(24,292)	222,014
Foreign Currency Translation Adjustment	(631)	(13,791)
Changes in Assets and Liabilities:
Decrease (Increase) in Accounts Receivable, net	1,857,061	(1,226,133)
Decrease (Increase) in Insurance Receivable	371,217	(500,000)
Decrease in Inventory	293,326	3,669,233
Decrease in Other Assets	930,847	75,570
(Decrease) Increase in Accounts Payable	(1,298,031)	2,709,133
(Decrease) Increase in Settlement Payable	(146,668)	666,667
Decrease in Lease Liability	(1,369,994)
Decrease in Other Liabilities	(1,228,671)	(2,109,802)
Decrease in Deferred License Revenue	(1,689,651)	(1,718,127)
Changes in Assets and Liabilities	(2,280,564)	1,566,541
Cash Used In Operating Activities	(21,953,959)	(14,635,691)
Cash Flows From Investing Activities:
Purchase of Investments Available-for-Sale	(34,202,301)	(18,483,694)
Sale of Investments Available-for-Sale	30,479,252	29,596,315
Purchase of Equipment	(448,896)	(589,541)
Purchase of Research and Development Licenses (Related Party)	(750,000)
Cash (Used in) Provided By Investing Activities	(4,921,945)	10,523,080
Cash Flows From Financing Activities:
Payments on Short Term Notes Payable	(763,422)
Proceeds from the Exercise of Employee Stock Options	147,900
Stock Retained in Satisfaction of Tax Liabilities	180,289	1,978
Cash Provided By (Used In) Financing Activities	18,583,318	(1,978)
Decrease In Cash and Cash Equivalents	(8,292,586)	(4,114,589)
Cash At Beginning Of Period	22,713,980	8,406,917
Cash At End Of Period	14,421,394	$ 4,292,328
Supplemental Disclosure of Noncash Investing and Financing Activities:
Insurance Financing Note Payable	1,145,133
Public offering
Cash Flows From Financing Activities:
Proceeds from the issuance of common stock	18,777,642
Offering Costs from the Issuance of Common Stock	(1,487,721)
At The Market [Member]
Cash Flows From Financing Activities:
Proceeds from the issuance of common stock	2,296,235
Offering Costs from the Issuance of Common Stock	$ (207,027)